Volume 30, Number 1—January 2024
Research Letter
Use of Doxycycline to Prevent Sexually Transmitted Infections According to Provider Characteristics
William S. Pearson
, Brian Emerson, Matthew Hogben, and Lindley Barbee
, Brian Emerson, Matthew Hogben, and Lindley Barbee
Table
Logistic regression models comparing STI providers with non–STI providers on practices regarding prophylactic use of doxycycline and beliefs about antimicrobial resistance, United States*
| Question/response | Likelihood |
|---|---|
| Do you ever or have you ever prophylactically prescribed doxycycline for the prevention of a sexually transmitted infection? By prophylactic use, we mean taking doxycycline to prevent infection ahead of or immediately after exposure risk; response: “yes” | |
| STI provider | aOR 2.76, 95% CI 2.20–3.48 |
| Non–STI provider |
Referent |
| I have seen an increase in antibiotic resistant infections among my patients over the past 5 years; response “agree” or “strongly agree” | |
| STI provider | aOR 1.00, 95% CI 0.81–1.23 |
| Non–STI provider |
Referent |
| I am concerned that the prophylactic use of doxycycline contributes to antibiotic resistance; response: “agree” or “strongly agree” | |
| STI provider | aOR 1.09, 95% CI 0.88–1.35 |
| Non–STI provider |
Referent |
| The benefits of prophylactically prescribing doxycycline to a patient who is at high risk of contracting a sexually transmitted infection outweigh the possibility of increasing antibiotic resistance; response: “agree” or “strongly agree” | |
| STI provider | aOR 1.53, 95% CI 1.25–1.89 |
| Non–STI provider | Referent |
*STI providers, n = 761; non–STI providers, n = 743. Controlled for age of provider, sex of provider, specialty of provider, and number of years in practice. aOR, adjusted odds ratio; STI, sexually transmitted infection.
Page created: October 31, 2023
Page updated: December 20, 2023
Page reviewed: December 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.